VISCHER advised ImmunOs Therapeutics AG on all legal issues related to the transaction. ImmunOs Therapeutics AG, a biopharmaceutical company leveraging its unique immune system modulating HLA-based...
ImmunOs Therapeutics AG’s $11 Million Series C Financing Round
ImmunOs Therapeutics’ CHF 71 Million Series B Financing Round
Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...